#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Heparin-induced thrombocytopenia – current options of laboratory diagnostics in the Czech Republic


Authors: P. Sadílek;  I. Fátorová;  P. Ďulíček
Authors‘ workplace: IV. interní hematologická klinika FN Hradec Králové
Published in: Transfuze Hematol. dnes,28, 2022, No. 3, p. 152-162.
Category: Review/Educational Papers
doi: https://doi.org/10.48095/cctahd2022prolekare.cz11

Overview

Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin treatment. It is caused by IgG class antibodies directed against the platelet factor 4 (PF4) /heparin complex with subsequent strong platelet activation. Despite anticoagulant therapy and thrombocytopenia, there is a high risk of venous and arterial thrombosis. Dia­gnosis of HIT requires both evidence of clinical symptoms and laboratory confirmation of pathogenic antibodies. We divide laboratory tests for the dia­gnosis of HIT into two groups, immunological and functional. Immunological (antigenic) tests are used to detect antibodies directed against the PF4/heparin complex. Functional assays are based on the ability of antibodies to activate donor platelets in the presence of heparin. The aim of this article is to present a brief overview of laboratory tests for the dia­gnosis of HIT available in the Czech Republic.

Keywords:

Immunoassays – Functional tests – heparin-induced thrombocytopenia (HIT) – laboratory dia­gnostics of HIT


Sources

1. Greinacher A, Juhl D, Strobel U, et al. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical signifikance of antiplatelet factor 4/heparin antibodies of the IgG, IgM and IgA classes. J Thromb Haemost. 2007; 5: 1666–1673.

2. Warkentin TE. Heparin-induced thrombocytopenia: A clinicopathologic syndrome. Thromb Haemost. 1999; 82: 439–447.

3. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992; 68: 95–96.

4. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994; 71: 247–251.

5. Rauova L, Zhai L, Kowalska MA, Gowthami MA, Douglas BC, Mortimer P. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: dia­gnostic and therapeutic implications. Blood. 2006; 107: 2346–2353.

6. Warkentin TE. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant /anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transfus Med Rev. 1996; 10: 249–258.

7. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdia­gnosis of heparin-induced thrombocytopenia? Am J Hematol. 2007; 82: 1037–1043.

8. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia. Thromb Haemost. 2016; 116 (5): 813–822.

9. Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factor for thrombosis. Thromb Haemost. 2005; 94: 132–135.

10. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T’s) for the dia­gnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006; 4: 759–765.

11. Greinacher A. Heparin-induced thrombocytopenia. J Thromb Haemost. 2009; 7 (1): 9–12.

12. Pouplard C, Gueret P, Fouassier M, et al. Prospective evaluation of the ‚4Ts‘ score and particle gel immunoassay specific to heparin/PF4 for the dia­gnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2007; 5: 1373–1379.

13. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001; 344: 1286–1292.

14. Warkentin TE. Laboratory dia­gnosis of heparin-induced thrombocytopenia. Int J Lab Hematol. 2019; 41 (1): 15–25.

15. Sun L, Gimotty PA, Lakshmanan S, Cuker A. Dia­gnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia. A systematic review and meta-analysis. Thromb Haemost. 2016; 115 (5): 1044–1055.

16. Warkentin TE, Sheppard JI, Raschke R, Greinacher A. Performance characteristics of a rapid assay for anti-PF4/heparin antibodies, the Particle Immuno Filtration Assay. J Thromb Haemost. 2007; 5 (11): 2308‐2310.

17. Sachs UJ, von Hesberg J, Santoso S, Bein G, Bakchoul T. Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT). Thromb Haemost. 2011; 106: 1197–1202.

18. https: //www.labmate-online.com/news/laboratory-products/3/stago-uk-ltd/launch-of-rapid-hit-exclusion-test-in-the-uk/20306 (staženo 20.3.2022)

19. Nagler M, Bachmann LM, ten Cate H, ten Cate-Hoek A. Dia­gnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2016; 127 (5): 546–557.

20. Eichler P, Raschke R, Lubenow N, Meyer O, Schwind P, Greinacher A. The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays. Br J Haematol. 2002; 116: 887–891.

21. Meyer O, Salama A, Pittet N, Schwind P. Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4). Lancet. 1999; 354: 1525–1526.

22. Schneiter S, Colucci G, Sulze I, Barizzi G, Lammle B, Alberio L. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA. J Thromb Haemost. 2009; 7: 1649–1655.

23. Alhaliq AR, Joshua D, Kershaw G, Dunkley S. The Diamed assay has a poor positive predictive value for HIT in a tertiary hospital referral setting. Int J Lab Hematol. 2007; 29 (1): 69–70.

24. Warkentin TE, Sheppard JI. Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev. 2006; 20 (4): 259–272.

25. Vissac AM, Catala M, Amiral J. Incidence of the various heparin dependent antibody isotypes in a group of patients with heparin induced thrombocytopenia. J Thromb Haemost. 2007; 5 Suppl: P-T-318.

26. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004; 2: 2133–2137.

27. Warkentin TE, Sheppard JI, Moore JC, Kelton JG. The use of well-characterized sera for the assessment of new dia­gnostic enzyme-immunoassay for the dia­gnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2010; 8: 216–218.

28. Warkentin TE, Sheppard JI, Moore JC, Moore KM, Sigouin CS, Kelton JG. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med. 2005; 146 (6): 341–346.

29. Bakchoul T, Giptner A, Najaoui A, Bein G, Santoso S, Sachs UJH. Prospective evaluation of immunoassay for the dia­gnosis of heparin-induced thrombocytopenia. J Thromb Haemost. 2009; 7: 1260–1265.

30. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the dia­gnosis of heparin-induced thrombocytopenia. Thromb Haemost. 2008; 100: 678–684.

31. Whitlatch NL, Kong DF, Metjian AD, Arepally GM, Ortel TL. Validation of the high-dose heparin confirmatory step for the dia­gnosis of heparin-induced thrombocytopenia. Blood. 2010; 116: 1761–1766.

32. Warkentin TE, Sheppard JI. No significant improvement in dia­gnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure. J Thromb Haemost. 2006; 4: 281–282.

33. Greinacher A, Ittermann T, Bagemuhl J, et al. Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests. J Thromb Haemost. 2010; 8: 2025–2031.

34. Altuntas F, Matevosyan K, Burner J, Shen YM, Sarode R. Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia. Eur J Haematol. 2008; 80: 429–435.

35. Baroletti S, Hurwitz S, Conti NA, Fanikos J, Piazza G, Goldhaber SZ. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med. 2012; 125: 44–49.

36. Husseinzadeh HD, Gimotty PA, Pishko AM, Buckley M, Warkentin TE, Cuker A. Dia­gnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis. J Thromb Haemost. 2017; 15 (6): 1203–1212.

37. Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab (PF4-H) ] for the dia­gnosis of immune heparin-induced thrombocytopenia. Thromb Res. 2017; 153: 108–117.

38. Warkentin TE, Greinacher A. Laboratory testing for heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin‐induced thrombocytopenia. 5th edn. Boca Raton, Florida, CRC Press, 2013; 272–314.

39. Warkentin TE, Sheppard JI, Linkins LA, Arnold DM, Nazy I. High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for dia­gnosis of HIT. Blood. 2018; 132 (12): 1345–1349.

40. Chong BH, Burgess J, Ismail F. The clinical usefulness of the platelet aggregation test for the dia­gnosis of heparin-induced thrombocytopenia. Thromb Haemost. 1993; 69: 344–350.

41. Galea V, Khaterchi A, Robert F, Gerotziafas G, Hatmi M, Elalamy I. Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia dia­gnosis: confirmation in a prospective study. Platelets. 2013; 24 (6): 441–447.

42. Favaloro EJ, McCaughan G, Mohammed S, et al. HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin-induced thrombocytopenia. Pathology. 2018; 50 (4): 426–436.

43. Elalamy I, Galea V, Hatmi M, Gerotziafas GT. Heparin-induced multiple electrode aggregometry: a potential tool for improvement of heparin-induced thrombocytopenia dia­gnosis. J Thromb Haemost. 2009; 7: 1932–1934.

44. Jin J, Baker SA, Hall ET, Gombar S, Bao A, Zehnder JL. Implementation of whole-blood impedance aggregometry for heparin-induced thrombocytopenia functional assay and case discussion. Am J Clin Pathol. 2019; 152: 50–58.

45. Padmanabhan A, Jones CG, Curtis BR, et al. A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia/thrombosis. Chest. 2016; 150 (3): 506–515.

46. Solano C, Mutsando H, Self M, Morel-Kopp MC, Mollee P. Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital. Blood Coagul Fibrinolysis. 2013; 24 (4): 365–370.

47. Eichler P, Budde U, Haas S, et al. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA. Thromb Haemost. 1999; 81: 625–629.

48. Tardy B, Lecompte T, Mullier F, Vayne C, Pouplard C. Detection of platelet-activating antibodies associated with heparin-induced thrombocytopenia. J Clin Med. 2020; 9 (4): 1226.

49. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for dia­gnosis heparin-associated thrombocytopenia. Thromb Haemost. 1991; 66: 734–736.

50. Warkentin TE, Hayward CP, Smith CA, Kelly PM, Kelton JG. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med. 1992; 120: 371–379.

51. Sheridan D, Carter C, Kelton JG. A dia­gnostic test for heparin-induced thrombocytopenia. Blood. 1986; 67: 27–30.

52. Warkentin TE, Arnold DM, Nazi I, Kelton JG. The platelet serotonin-release assay. Am J Hematol. 2015; 90 (6): 564–572.

53. Moore JC, Arnold DM, Warkentin TE, Warkentin AE, Kelton JG. An algorithm for resolving indeterminate test results in the platelet serotonin release assay for investigation of heparin-induced thrombocytopenia. J Thromb Haemost. 2008; 6: 1595–1597.

54. Fouassier M, Bourgerette E, Libert F, Pouplard C, Marques-Verdier A. Determination of serotonin release from platelets by HPLC and ELISA in the dia­gnosis of heparin-induced thrombocytopenia: comparison with reference method by [14C]-serotonin release assay. J Thromb Haemost. 2006; 4: 1136–1139.

55. Lee DP, Warkentin TE, Denomme GA, Hayward CPM, Kelton JG. A dia­gnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol. 1996; 95: 724–731.

56. Gobbi G, Mirandola P, Tazzari PL, et al. Flow cytometry detection of serotonin content and release in resting and activated platelets. Br J Haematol. 2003; 121: 892–896.

Labels
Haematology Internal medicine Clinical oncology

Article was published in

Transfusion and Haematology Today

Issue 3

2022 Issue 3

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#